About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT07452354

AI-Based Diabetic Foot Recurrence Cohort

Diabetic foot ulcer (DFU) is a major adverse outcome of diabetes, which itself is one of the most significant chronic diseases. The recurrence of DFU involves multiple risk factors, including altered ...

Lead sponsor: Peking University Third Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Long Zhang Executive Deputy Director, Medical Doctor

CONTACT

+86 010-82266699 liyunfeng1106@163.com

Sponsors

Lead Sponsor

Peking University Third Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•The patient must be aged 18 years or older; have a confirmed diagnosis of type 1 or type 2 diabetes mellitus according to the World Health Organization criteria; the wound etiology attributable to diabetic foot ulcers, with complete wound healing post-treatment defined as a dry wound devoid of exudate, complete epithelialization of both the wound bed and margins, absence of surrounding erythema or edema, and sufficient tensile strength to withstand pressure without dehiscence; voluntary participation in this study with provision of written informed consent.

Exclusion Criteria

•Inability of the patient to cooperate or presence of psychiatric disorders; At the investigator's discretion, the subject is deemed unsuitable for this study or unable to comply with the study requirements.

Related studies

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

NCT07605572 · Dry Eye Disease (DED), Diabete Mellitus, and more

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

NCT07550777 · Diabete Mellitus, Retina Vein Occlusion, and more

PAW-Hydrogel for Chronic Wound Healing

NCT07541196 · Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU), and more

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697 · Erectile Disfunction, Coronary Artery Disease (CAD), and more

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

NCT06449638 · Diabetic Foot Ulcer (DFU), Ulcer Foot, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment200

Start dateMar 2026

Last updatedMar 5, 2026

Condition

Diabetic Foot Ulcer (DFU)Diabete Mellitus Diabetic Foot Ulcer Treatment Artificial Intelligence (AI) in Diagnosis

Locations shown

Peking University Third Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions